These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30899214)

  • 21. Depletion of the Fragile X Mental Retardation Protein in Embryonic Stem Cells Alters the Kinetics of Neurogenesis.
    Khalfallah O; Jarjat M; Davidovic L; Nottet N; Cestèle S; Mantegazza M; Bardoni B
    Stem Cells; 2017 Feb; 35(2):374-385. PubMed ID: 27664080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: The relevance of early life phases.
    Gaudissard J; Ginger M; Premoli M; Memo M; Frick A; Pietropaolo S
    Autism Res; 2017 Oct; 10(10):1584-1596. PubMed ID: 28590057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome.
    Qin M; Huang T; Kader M; Krych L; Xia Z; Burlin T; Zeidler Z; Zhao T; Smith CB
    Int J Neuropsychopharmacol; 2015 Mar; 18(9):. PubMed ID: 25820841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tactile Defensiveness and Impaired Adaptation of Neuronal Activity in the
    He CX; Cantu DA; Mantri SS; Zeiger WA; Goel A; Portera-Cailliau C
    J Neurosci; 2017 Jul; 37(27):6475-6487. PubMed ID: 28607173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice.
    Bostrom CA; Majaess NM; Morch K; White E; Eadie BD; Christie BR
    Cereb Cortex; 2015 Jan; 25(1):271-9. PubMed ID: 23968838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragile X mice: reduced long-term potentiation and N-Methyl-D-Aspartate receptor-mediated neurotransmission in dentate gyrus.
    Yun SH; Trommer BL
    J Neurosci Res; 2011 Feb; 89(2):176-82. PubMed ID: 21162125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats.
    Ruby K; Falvey K; Kulesza RJ
    Neuroscience; 2015 Sep; 303():285-98. PubMed ID: 26166728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions.
    Bach S; Shovlin S; Moriarty M; Bardoni B; Tropea D
    Front Cell Neurosci; 2021; 15():764761. PubMed ID: 34867203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of the GABAergic pathway for the treatment of fragile X syndrome.
    Lozano R; Hare EB; Hagerman RJ
    Neuropsychiatr Dis Treat; 2014; 10():1769-79. PubMed ID: 25258535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced Excitatory Connectivity and Disturbed Sound Processing in the Auditory Brainstem of Fragile X Mice.
    Garcia-Pino E; Gessele N; Koch U
    J Neurosci; 2017 Aug; 37(31):7403-7419. PubMed ID: 28674175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human pluripotent stem cell models of Fragile X syndrome.
    Bhattacharyya A; Zhao X
    Mol Cell Neurosci; 2016 Jun; 73():43-51. PubMed ID: 26640241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed Maturation of Fast-Spiking Interneurons Is Rectified by Activation of the TrkB Receptor in the Mouse Model of Fragile X Syndrome.
    Nomura T; Musial TF; Marshall JJ; Zhu Y; Remmers CL; Xu J; Nicholson DA; Contractor A
    J Neurosci; 2017 Nov; 37(47):11298-11310. PubMed ID: 29038238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse.
    Louhivuori V; Vicario A; Uutela M; Rantamäki T; Louhivuori LM; Castrén E; Tongiorgi E; Akerman KE; Castrén ML
    Neurobiol Dis; 2011 Feb; 41(2):469-80. PubMed ID: 21047554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modelling fragile X syndrome in the laboratory setting: A behavioral perspective.
    Melancia F; Trezza V
    Behav Brain Res; 2018 Sep; 350():149-163. PubMed ID: 29704597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The psychiatric presentation of fragile x: evolution of the diagnosis and treatment of the psychiatric comorbidities of fragile X syndrome.
    Tranfaglia MR
    Dev Neurosci; 2011; 33(5):337-48. PubMed ID: 21893938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome.
    Pellerin D; Lortie A; Corbin F
    Platelets; 2018 Mar; 29(2):113-124. PubMed ID: 28660769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
    De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
    Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired bidirectional NMDA receptor dependent synaptic plasticity in the dentate gyrus of adult female Fmr1 heterozygous knockout mice.
    Yau SY; Bostrom CA; Chiu J; Fontaine CJ; Sawchuk S; Meconi A; Wortman RC; Truesdell E; Truesdell A; Chiu C; Hryciw BN; Eadie BD; Ghilan M; Christie BR
    Neurobiol Dis; 2016 Dec; 96():261-270. PubMed ID: 27659109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders.
    Bagni C; Zukin RS
    Neuron; 2019 Mar; 101(6):1070-1088. PubMed ID: 30897358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Event-related potential alterations in fragile X syndrome.
    Knoth IS; Lippé S
    Front Hum Neurosci; 2012; 6():264. PubMed ID: 23015788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.